DaVita HealthCare Partners Inc (DVA)
Healthcare | Specialized Health Services
CEO: Kent J. Thiry
DaVita HealthCare Partners Inc receives an in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. DaVita HealthCare Partners Inc's valuation score is comprised of a P/E ratio of 10.3x, a P/B ratio of 2.5x, a P/S ratio of 0.8x, and an EV/EBITDA ratio of 6.5x. .
WARREN BUFFETT RANKING
DaVita HealthCare Partners Inc ranks 56 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors.
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.
DaVita HealthCare Partners Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.84x, a debt/equity ratio of 144% and a Moat Rank of 289 translate to an average Financial Strength score.
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -12.37% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 460.
VALUE + YIELD
DaVita HealthCare Partners Inc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology.
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. Its 11.4% 5 year annualized EPS growth, 16.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 15.9% speak to its impressive growth ranking.